Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for political professionals · Wednesday, January 8, 2025 · 775,229,286 Articles · 3+ Million Readers

Infertility Treatment Market Size to Reach USD 3.512 Billion by 2032 – Share & Growth Report

Infertility Treatment Market

Infertility Treatment Market

Market Growth is Driven by Technological Advancements, Rising Awareness, and Government Support

AUSTIN, TX, UNITED STATES, January 7, 2025 /EINPresswire.com/ -- According to Research by SNS Insider, The Infertility Treatment market size was estimated at USD 1.745 billion in 2023 and is expected to reach USD 3.512 billion by 2032 at a CAGR of 8.02% during the forecast period of 2024-2032.

Infertility Treatment Market, Advancing Solutions for a Growing Global Challenge
The infertility treatment market is experiencing robust growth, driven by several factors, including declining fertility rates, the rise of fertility clinics, and advancements in assisted reproductive technologies (ART) such as in vitro fertilization (IVF). Technological innovations like AI-based embryo selection and non-invasive genetic screening are improving success rates, and boosting patient confidence. Additionally, the growing support from both public and private sectors, alongside evolving insurance policies, is making fertility treatments more accessible and affordable. Governments are also playing a significant role by eliminating financial barriers and raising awareness, positioning the market for further expansion as demand for effective infertility solutions continues to rise globally.

Get a Free Sample Report of Infertility Treatment Market @ https://www.snsinsider.com/sample-request/4830

Key Market Players in Infertility Treatment Market
- Merck & Co., Inc. (Gonal-f, Ovidrel)
- Ferring Pharmaceuticals (Menopur, Bravelle)
- CooperSurgical, Inc. (Sage IUI Catheter, Wallace Embryo Replacement Catheter)
- Vitrolife AB (EmbryoScope+, VitroLife Cleav Media)
- Cook Medical (K-MICR Catheter, MINC Incubator)
- Fisher Scientific (IVF Witness, Vitrogen IVF Media)
- Irvine Scientific (Continuous Single Culture (CSC) Media, ISolate Sperm Separation System)
- Esco Medical (Miri Time-Lapse Incubator, Mini Miri Benchtop Incubator)
- Origio (SpermFreeze Solution, ORIGIO Sequential Cleav Media)
- Genea Biomedx (Gavi, Geri Incubator)
- INVO Bioscience (INVOcell, INVO Pre-treatment Kit)
- FUJIFILM Irvine Scientific (ISolate Media, Vit Kit-Freeze Media)
- Hamilton Thorne Ltd. (Lykos Laser System, IMSI-Strict Software)
- Nidacon International AB (PureSperm Wash, PureSperm Buffer)
- Cryoport, Inc. (Cryoport Express Shipper, Cryoportal Logistics Platform)
- Vitrolife Group (EmbryoGen, Primo Vision)
- Ava AG (Ava Fertility Tracker, Ava Core)
- Research Instruments Ltd. (Saturn 5 Laser System, RI Witness)
- OXFORD Gene Technology (OGT) (CytoSure Fertility Array, IVF Genotyping Array)
- Kitazato Corporation (Cryotop Method, Oocyte Retrieval Needle)

Segment Analysis

By Product
The equipment segment dominated the market in 2023, which is attributed to slight advancements in technologies of reproductive health devices Similarly, state-of-the-art imaging systems, egg collection devices, and sperm analysis tools are enhancing the accuracy and outcomes of treatments. Such technologies are available now, and more awareness and upfront efforts toward developing infrastructure in these developing nations are also driving demands in this segment.

By Procedure
The ART segment dominated the market with a market share of 50% in 2023. Better success rates and higher acceptance are the major reasons these techniques like IVF and Intracytoplasmic Sperm Injection (ICSI) have gained popularity worldwide. The increasing insurance coverage for ART in the majority of the regions and the adoption of AI technologies to improve the success rate are also aiding this segment. This segment has also led government initiatives to raise awareness about ART.

Need any customization research on Infertility Treatment Market, Enquire Now @ https://www.snsinsider.com/enquiry/4830

Key Market Segmentation:
By Product
• Equipment
• Media & Consumables
• Accessories

By Procedure
• Assisted Reproductive Technology
• Artificial Insemination
• Fertility Surgeries
• Other Infertility Treatment Procedures

By Patient Type
• Female Infertility Treatment
• Male Infertility Treatment

By End User
• Fertility Centers
• Hospitals & Surgical Clinics
• Cryobanks
• Research Institutes

Regional Insights
The Asia Pacific region dominated the global market in 2023 with a 35% share and is expected to continue leading throughout the forecast period. Growth in this region is fueled by increased medical tourism, heightened awareness about infertility treatments, and a rising number of fertility clinics. Major contributors to this expansion are countries such as India, China, Japan, and South Korea, which are supported by government initiatives, urbanization, and rising disposable incomes. There is also a huge opportunity building with a decline in the cost of treatments and better facilities available in developing countries.

North America is expected to grow at a relatively fastest growth rate due to favorable remuneration policies and the increasing prevalence of infertility. Huge investments in research and development and the availability of advanced technologies for this region will serve as drivers in the market. Increased patient awareness and favorable regulation will further enhance the growth trajectory of the market.

Recent Market Developments
• February 2024: Lupin Limited, a global biopharmaceutical leader, announced the launch of Ganirelix Acetate Injection after receiving U.S. FDA approval. This product is designed to prevent ovulation induction during controlled ovarian hyperstimulation, marking a significant advancement in fertility treatments.
• July 2023: BPEA EQT acquired a majority stake in Indira IVF, India’s leading fertility service provider and one of the top global players in annual IVF cycles. With over 125,000 successful pregnancies to date, this acquisition underscores the growing investment in the infertility treatment sector.

Buy Full Research Report on Infertility Treatment Market 2024-2032 @ https://www.snsinsider.com/checkout/4830

Table of Contents – Major Key Points
1. Introduction
2. Executive Summary
3. Research Methodology
4. Market Dynamics Impact Analysis
5. Statistical Insights and Trends Reporting
6. Competitive Landscape
7. Infertility Treatment Market by Product
8. Infertility Treatment Market by Procedure
9. Infertility Treatment Market by Patient Type
10. Infertility Treatment Market by End User
11. Regional Analysis
12. Company Profiles
13. Use Cases and Best Practices
14. Conclusion

Speak with Our Expert Analyst Today to Gain Deeper Insights @ https://www.snsinsider.com/request-analyst/4830

About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Browse More Insights:
Fertility Services Market Report
In Vitro Fertilization (IVF) Market Report

Akash Anand
SNS Insider Pvt. Ltd
415-230-0044
email us here
Visit us on social media:
Facebook
X
LinkedIn
Instagram

Powered by EIN Presswire

Distribution channels: Healthcare & Pharmaceuticals Industry

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release